Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2010
05/06/2010US20100113502 Novel Tetrahydro-1H-Pyrido[4,3-b] Indole Derivatives as CB1 Receptor Ligands
05/06/2010US20100113501 Ophthalmic Composition Comprising Ascomycin
05/06/2010US20100113500 Orally bioavailable products of (+)-3-hydroxymorphinan for parkinson's disease prevention or treatment
05/06/2010US20100113499 Medicament for the treatment of endometriosis
05/06/2010US20100113498 Novel vinblastine derivatives, their preparation, use and pharmaceutical compositions comprising the said derivatives
05/06/2010US20100113497 Gaba conjugates and methods of use thereof
05/06/2010US20100113496 Piperidine modulators of vmat2
05/06/2010US20100113495 Pharmaceutical compositions comprising an opioid receptor antagonist and methods of using same
05/06/2010US20100113494 13,13a-Dihydroberberine Derivatives For Use In Pharmaceutical Compositions
05/06/2010US20100113493 (pyrrolidin-2-yl)phenyl derivatives
05/06/2010US20100113492 Substituted Aminopyrimidines as Cholecystokinin-1 Receptor Modulators
05/06/2010US20100113491 Synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs
05/06/2010US20100113489 Modulators of chemokine receptor activity, crystalline forms and process
05/06/2010US20100113488 Macrocyclic factor viia inhibitors useful as anticoagulants
05/06/2010US20100113487 Pyrimidinone derivatives and methods of use thereof
05/06/2010US20100113486 Use of pde7 inhibitors for the treatment of movement disorders
05/06/2010US20100113485 Piperidinylamino-thieno[2,3-D] Pyrimidine Compounds
05/06/2010US20100113484 Treating agent of uropathy
05/06/2010US20100113483 Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditions
05/06/2010US20100113482 Novel Compounds for Treating Mental Disorders, and Preparation and Uses Thereof
05/06/2010US20100113481 Use of serum amyloid a gene in diagnosis and treatment of glaucoma and identification of anti-glaucoma agents
05/06/2010US20100113480 Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists
05/06/2010US20100113479 Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists
05/06/2010US20100113478 Indolone modulators of 5-ht3 receptor
05/06/2010US20100113477 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof
05/06/2010US20100113476 Chemical linkers with single amino acids and conjugates thereof
05/06/2010US20100113475 Pyrazolylaminopyridines as inhibitors of fak
05/06/2010US20100113474 Antineoplastic Combinations of 4-Anilino-3-Cyanoquinolines and Capecitabine
05/06/2010US20100113473 Aryl amide compound as an acetyl coenzyme a carboxylase inhibitor
05/06/2010US20100113472 Compounds for the treatment of osteoporosis and cancers
05/06/2010US20100113471 2-Aminoaryloxazole compounds as tyrosine kinase inhibitors
05/06/2010US20100113470 Bcr-abl variants
05/06/2010US20100113469 Combination therapy for the treatment-of lower urinary tract symptoms
05/06/2010US20100113468 Quinazoline derivatives as kinase inhibitors
05/06/2010US20100113467 Organic Compounds
05/06/2010US20100113466 Oxazole-pyridazine-oxazole alpha-helix mimetic
05/06/2010US20100113465 7-azaspiro[3.5]nonane-7-carboxamide compounds
05/06/2010US20100113464 Novel pyridazine derivatives
05/06/2010US20100113463 PTERIDINONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
05/06/2010US20100113462 Substituted benzoylamino-indan-2-carboxylic acids and related compounds
05/06/2010US20100113461 Substituted heterocyclic compounds
05/06/2010US20100113460 Organic Compounds
05/06/2010US20100113459 Gene Polymorphisms as Predictors of Tumor Progression and Their Use in Cancer Therapy
05/06/2010US20100113458 Imidazopyridazinecarbonitriles useful as kinase inhibitors
05/06/2010US20100113456 Therapeutic agent for corneal disease
05/06/2010US20100113455 Method of reducing intraosseous hypertension
05/06/2010US20100113454 Pyrrolotriazine kinase inhibitors
05/06/2010US20100113453 Sublingual Formulations of D-Cycloserine and Methods of Using Same
05/06/2010US20100113452 Compounds for treating pulmonary hypertension
05/06/2010US20100113451 Novel preventive and/or therapeutic agent for diabetic neuropathy
05/06/2010US20100113450 Agent for Preventing and Alleviating Wrinkles
05/06/2010US20100113449 Fused heterocyclic compounds as ion channel modulators
05/06/2010US20100113448 Oxazolidinone derivative having inhibitory activity on 11beta-hydroxysteroid dehydrogenase type 1
05/06/2010US20100113447 Triazole compounds that modulate hsp90 activity
05/06/2010US20100113446 Hydantoin compounds
05/06/2010US20100113445 Chemical Compounds
05/06/2010US20100113444 Prolyl hydroxylase inhibitors
05/06/2010US20100113443 Liquid formulations of phospholipase enzyme inhibitors
05/06/2010US20100113442 Triazolopyridines as phosphodiesterase inhibitors for treatment of dermal diseases
05/06/2010US20100113441 Substituted imidazopyrimidines and triazolopyrimidines
05/06/2010US20100113440 Pyrimidine substituted macrocyclic hcv inhibitors
05/06/2010US20100113439 Antifungal agents
05/06/2010US20100113438 Class of histone deacetylase inhibitors
05/06/2010US20100113436 Dispiro tetraoxane compounds and their use in the treatment of malaria and/or cancer
05/06/2010US20100113435 Inhibitors of 11-beta-hydroxy steriod dehydrogenase type 1
05/06/2010US20100113434 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
05/06/2010US20100113433 N-Substituted Thiomorpholine Derivatives as the Inhibitors of Dipeptidyl Peptidase IV and the Pharmaceutical Uses Thereof
05/06/2010US20100113432 Phenothiazine modulators of d2 receptors and 5-ht2 receptors
05/06/2010US20100113431 N-methyl piperazine modulators of h1 receptor
05/06/2010US20100113430 Thioxanthene derivates useful to treat infectious diseases
05/06/2010US20100113429 Inhibitors of ftsz and uses thereof
05/06/2010US20100113428 Diazabicyclic aryl derivatives as cholinergic receptor modulators
05/06/2010US20100113427 Compositions of 5-ht3 antagonists and dopamine d2 antagonists for treatment of dopamine-associated chronic conditions
05/06/2010US20100113426 Intranasal Benzodiazepine Compositions
05/06/2010US20100113425 Pyrrolobenzodiazepines
05/06/2010US20100113424 N-benzyl pyrrolidine derivatives
05/06/2010US20100113423 Modulators of Aldehyde Dehydrogenase and Methods of Use Thereof
05/06/2010US20100113422 Pyrimido [4,5-D] Azepine Derivatives As 5-HT2C Agonists
05/06/2010US20100113421 Non-nucleoside reverse transcriptase inhibitors
05/06/2010US20100113420 Pyrrolopyrimidine derivatives as jak3 inhibitors
05/06/2010US20100113419 Cgrp receptor antagonists
05/06/2010US20100113418 Heterocyclic compound
05/06/2010US20100113417 Substituted Spiroamine Compounds
05/06/2010US20100113416 Janus kinase inhibitors for treatment of dry eye and other eye related diseases
05/06/2010US20100113415 Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer
05/06/2010US20100113414 Thiazolyl-dihydro-indazoles
05/06/2010US20100113413 MAPK/ERK Kinase Inhibitors
05/06/2010US20100113412 IMIDAZO[1,2-a]PYRIDINES AND THEIR USE AS PHARMACEUTICALS
05/06/2010US20100113411 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
05/06/2010US20100113410 Pyrazolopyrimidine derivative
05/06/2010US20100113409 Hydrochloride salt of 5-[3-(3-hydroxyphenoxy) azetidin-1-yl]-5-methyl-2,2-diphenylhexanamide
05/06/2010US20100113408 21-substituted progesterone derivatives as new antiprogestational agents
05/06/2010US20100113407 Androgen treatment in females
05/06/2010US20100113406 Use of glucocorticoids for treatment of congestive heart failure
05/06/2010US20100113405 Methylindazole modulators of 5-ht3 receptors
05/06/2010US20100113404 Anti-angiogenic activity of 2-methoxyestradiol analogs in combination with anti-cancer agents
05/06/2010US20100113403 Compositions containing compounds having steroid structure and their use for inducing the proliferation and differentiation of stem cells of the organism
05/06/2010US20100113402 Compositions for treatment of inflammatory diseases
05/06/2010US20100113401 Methods for synthesizing and purifying aminoalkyl tetracycline compounds
05/06/2010US20100113400 9-Aminomethyl Substituted Minocycline Compounds
1 ... 2280 2281 2282 2283 2284 2285 2286 2287 2288 2289 2290 2291 2292 2293 2294 2295 2296 2297 2298 2299 2300 ... 7860